Terms: = Skin cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1
171 results:
1. Comparison of chitosan nanoparticles containing Lippia citriodora essential oil and citral on the induction of apoptosis in A375 melanoma cells.
Karimivaselabadi A; Osanloo M; Ghanbariasad A; Zarenezhad E; Hosseini H
BMC Complement Med Ther; 2023 Dec; 23(1):435. PubMed ID: 38041055
[TBL] [Abstract] [Full Text] [Related]
2. Comparison effects of Ferula gummosa essential oil and Beta-pinene Alginate nanoparticles on human melanoma and breast cancer cells proliferation and apoptotic index in short term normobaric hyperoxic model.
Osanloo M; Pishamad S; Ghanbariasad A; Zarenezhad E; Alipanah M; Alipanah H
BMC Complement Med Ther; 2023 Nov; 23(1):428. PubMed ID: 38017466
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032.
Eedara BB; Manivannan B; Alabsi W; Sun B; Curiel-Lewandrowski C; Zhang T; Bode AM; Mansour HM
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958502
[TBL] [Abstract] [Full Text] [Related]
4. A comprehensive overview of psoriatic research over the past 20 years: machine learning-based bibliometric analysis.
Yu C; Huang Y; Yan W; Jiang X
Front Immunol; 2023; 14():1272080. PubMed ID: 37954610
[TBL] [Abstract] [Full Text] [Related]
5. Web-Based Video Education to Improve Uptake of Influenza Vaccination and Other Preventive Health Recommendations in Adults With Inflammatory Bowel Disease: Randomized Controlled Trial of Project PREVENT.
Long MD; van Deen WK; Weisbein L; Khalil C; Appel KL; Zhang X; Chen W; Zubrod L; Maris R; Ghafari A; Dupuy T; Ha CY; Spiegel BMR; Almario CV; Melmed GY
J Med Internet Res; 2023 Aug; 25():e42921. PubMed ID: 37610821
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of Quinolinequinone Analogs with Promising Cytotoxic Activity against Breast cancer.
Yilmaz Goler AM; Tarbin Jannuzzi A; Biswas A; Mondal S; Basavanakatti VN; Jayaprakash Venkatesan R; Yıldırım H; Yıldız M; Çelik Onar H; Bayrak N; Jayaprakash V; TuYuN AF
Chem Biodivers; 2023 Sep; 20(9):e202300848. PubMed ID: 37590495
[TBL] [Abstract] [Full Text] [Related]
7. Is Dissection and Preservation of Adherent Popliteal Vessels From a Posterior Soft Tissue Mass Associated With a Higher Proportion of Local Recurrence in Patients With a Distal Femoral Osteosarcoma?
Ebeid W; Elghoneimy A; Abousenna W
Clin Orthop Relat Res; 2023 Nov; 481(11):2167-2176. PubMed ID: 37527334
[TBL] [Abstract] [Full Text] [Related]
8. Chrysin-Induced Regression of Angiogenesis via an Induction of DNA Damage Response and Oxidative Stress in In Vitro and In Vivo Models of Melanoma.
Sassi A; Fredon M; Cotte AK; Fuselier C; Schneider C; Martiny L; Monchaud D; Chekir-Ghedira L; Aires V; Delmas D
Cells; 2023 Jun; 12(12):. PubMed ID: 37371032
[TBL] [Abstract] [Full Text] [Related]
9. A drug safety evaluation of pemigatinib for advanced cholangiocarcinoma.
Uson PLS; Bearss J; Babiker HM; Borad M
Expert Opin Drug Saf; 2023; 22(8):637-641. PubMed ID: 37363820
[TBL] [Abstract] [Full Text] [Related]
10. Endoscopic hemithyroidectomy plus prophylactic central neck dissection via breast approach versus gasless transaxillary approach in treating low-risk papillary thyroid cancer: a retrospective series.
Zhang X; Hu XJ; Hua KJ
Updates Surg; 2023 Apr; 75(3):707-715. PubMed ID: 36848003
[TBL] [Abstract] [Full Text] [Related]
11. Factors affecting eye conservation and metastasis in posterior uveal melanomas.
Nalcı Baytaroğlu H; Gündüz AK; Mirzayev I; Özalp Ateş FS
Eur J Ophthalmol; 2023 Sep; 33(5):2024-2033. PubMed ID: 36762394
[TBL] [Abstract] [Full Text] [Related]
12. Nano-scaled emulsion and nanogel containing Mentha pulegium essential oil: cytotoxicity on human melanoma cells and effects on apoptosis regulator genes.
Azadi S; Osanloo M; Zarenezhad E; Farjam M; Jalali A; Ghanbariasad A
BMC Complement Med Ther; 2023 Jan; 23(1):6. PubMed ID: 36624422
[TBL] [Abstract] [Full Text] [Related]
13. Ring finger protein 126 promotes breast cancer metastasis and serves as a potential target to improve the therapeutic sensitivity of atr inhibitors.
Pan Y; Yang Y; Huang R; Yang H; Huang Q; Ji Y; Dai J; Qiao K; Tang W; Xie L; Yin M; Ouyang J; Ning S; Su D
Breast Cancer Res; 2022 Dec; 24(1):92. PubMed ID: 36539893
[TBL] [Abstract] [Full Text] [Related]
14. Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts.
Scheper J; Hildebrand LS; Faulhaber EM; Deloch L; Gaipl US; Symank J; Fietkau R; Distel LV; Hecht M; Jost T
Strahlenther Onkol; 2023 Dec; 199(12):1128-1139. PubMed ID: 36229655
[TBL] [Abstract] [Full Text] [Related]
15. Characteristics and outcomes of heart transplant recipients with a pretransplant history of malignancy.
Youn JC; Kim D; Kim KA; Kim JJ; Kim IC; Lee HS; Choi JO; Jeon ES; Nishihara K; Kransdorf EP; Chang DH; Kittleson MM; Patel JK; Ramzy D; Esmailian F; Kobashigawa JA
Am J Transplant; 2022 Dec; 22(12):2942-2950. PubMed ID: 36050598
[TBL] [Abstract] [Full Text] [Related]
16. Local recurrence risk in head and neck basal cell carcinoma.
Szewczyk M; Pazdrowski J; Pabiszczak M; Więckowska B; Dańczak-Pazdrowska A; Golusiński W
Otolaryngol Pol; 2022 Jun; 76(4):1-5. PubMed ID: 36047328
[TBL] [Abstract] [Full Text] [Related]
17. Onset of p53/NF-κB signaling crosstalk in human melanoma cells in response to anti-cancer theabrownin.
Li T; Yan B; Xiao X; Zhou L; Zhang J; Yuan Q; Shan L; Wu H; Efferth T
FASEB J; 2022 Aug; 36(8):e22426. PubMed ID: 35779042
[TBL] [Abstract] [Full Text] [Related]
18. Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.
Dimitriou F; Namikawa K; Reijers ILM; Buchbinder EI; Soon JA; Zaremba A; Teterycz P; Mooradian MJ; Armstrong E; Nakamura Y; Vitale MG; Tran LE; Bai X; Allayous C; Provent-Roy S; Indini A; Bhave P; Farid M; Kähler KC; Mehmi I; Atkinson V; Klein O; Stonesifer CJ; Zaman F; Haydon A; Carvajal RD; Hamid O; Dummer R; Hauschild A; Carlino MS; Mandala M; Robert C; Lebbe C; Guo J; Johnson DB; Ascierto PA; Shoushtari AN; Sullivan RJ; Cybulska-Stopa B; Rutkowski P; Zimmer L; Sandhu S; Blank CU; Lo SN; Menzies AM; Long GV
Ann Oncol; 2022 Sep; 33(9):968-980. PubMed ID: 35716907
[TBL] [Abstract] [Full Text] [Related]
19. Model-based dose selection to inform translational clinical oncology development of WNT974, a first-in-class Porcupine inhibitor.
Ji Y; Huang PH; Woolfenden S; Myers A
Clin Transl Sci; 2022 Jul; 15(7):1713-1722. PubMed ID: 35620969
[TBL] [Abstract] [Full Text] [Related]
20. Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment.
Maresca L; Stecca B; Carrassa L
Cells; 2022 Apr; 11(9):. PubMed ID: 35563772
[TBL] [Abstract] [Full Text] [Related]
[Next]
